lung disease

Another RA-backed biotech hits Nasdaq as public market stirs again after a bruising first quarter
Endpoints
Fri, 03/25/22 - 10:29 am
AN2 Therapeutics
lung disease
funding
RA Capital
venture capital
IPOs
With lung drug from Pfizer in hand, AN2 tests IPO waters in turbulent market
MedCity News
Tue, 03/8/22 - 10:01 am
AN2 Therapeutics
Okyo Pharma
IPOs
clinical trials
lung disease
dry eye disease
Bayer, Boston academics form joint lab to research lung disease
Fierce Biotech
Tue, 09/24/19 - 09:39 am
Bayer
Brigham and Women's
Massachusetts General Hospital
lung disease
R&D
CureVac and Yale Team Up for mRNA-Based Lung Therapies
BioSpace
Tue, 08/13/19 - 04:41 pm
CureVac
Yale
MRNA
lung disease
R&D
Your inhaler’s watching you: drugmakers race for smart devices
Mass Device
Thu, 07/21/16 - 08:57 am
devices
asthma
lung disease
inhalers
GSK
AstraZeneca
Novartis
smart devices
4 Key Drug Approvals Expected In The Next 30 Days
investors.com
Sat, 03/16/13 - 10:55 am
Biogen Idec
BG-12
multiple sclerosis
MS
Remodulin
United Therapeutics
lung disease
Invokana
JNJ
diabetes
type 2 diabetes
Levadex
Allergan
migraine
Glaxo, Theravance report Relovair safety data
Yahoo/AP
Wed, 09/22/10 - 09:57 am
GSK
Theravance
asthma
lung disease
Relovair
Forest's lung disease drug fails mid-stage trial
Yahoo/AP
Wed, 08/19/09 - 08:27 am
Forest Labs
lung disease
drug trials
oglemilast